Effectiveness and safety of apixaban therapy in daily-care patients with atrial fibrillation: results from the Dresden NOAC Registry
Crossref DOI link: https://doi.org/10.1007/s11239-017-1519-8
Published Online: 2017-06-22
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Helmert, Sindy
Marten, Sandra
Mizera, Heike
Reitter, Antje
Sahin, Kurtulus
Tittl, Luise
Beyer-Westendorf, Jan
Funding for this research was provided by:
Bayer HealthCare
Pfizer Foundation
Boehringer Ingelheim
Daiichi-Sankyo
License valid from 2017-06-22